SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
--------------
Date of Report (Date of earliest event reported): April 24, 2003
EPIX Medical, Inc.
(Exact name of registrant as specified in its charter)
Delaware 000-21863 04-3030815
------------------------- ----------------------- ----------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
71 Rogers Street
Cambridge, Massachusetts 02142
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 250-6000
Item 7. Financial Statements and Exhibits.
(c) The following exhibits are furnished with this report:
Exhibit Number Description
99.1 Press Release dated April 24, 2003.
Item 9. Regulation FD Disclosure.
The following information is furnished pursuant to Item 12, "Disclosure of
Results of Operations and Financial Condition."
On April 24, 2003, the Registrant issued a press release to report its financial
results for the quarter ended March 31, 2003. A copy of the press release is
attached to this current report on Form 8-K as Exhibit 99.1.
In accordance with the procedural guidance in SEC Release No. 33-8216, the
information in this Form 8-K and the Exhibit attached to this Form 8-K are being
furnished under "Item 9. Regulation FD Disclosure" in satisfaction of the
requirements of "Item 12. Disclosure of Results of Operations and Financial
Condition." This information shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EPIX Medical, Inc.
(Registrant)
Date: April 24, 2003 By: /s/ Peyton J. Marshall
-----------------------------------------
Peyton J. Marshall
Senior Vice-President,
Finance and Administration,
Chief Financial Officer